The role of the gut microbiome in the development of side effects of anti cancer treatment will be assessed in this longitudinal cohort study.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* 18 years or older
* Start of a systemic anti-cancer therapy
* Informed consent
Exclusion Criteria:
* • Pre-existing diarrhoea
* Antibiotic therapy -4 to -1 week before inclusion
* Probiotic treatment -4 to -1 week before inclusion
* Inability to give informed consent
Primary outcome measure(s)
gut microbiome composition — 4-12 weeks 16s sequencing
Trial sites (1)
Facility
City
Region
Status
Department of Internal Medicine, Medical University of Graz
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.